Although point mutations and gene amplification of Src alone are not frequent, the total alteration rates among all the Src-family members combined (most of which are cases of gene amplification) are detected in 13% of the breast cancer patients, whose overall survival is shorter than patients without these changes (cBioportal for Cancer Genomics). Here, SRC is linked to breast carcinoma.